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Abstract:  
The main treatment of insulin-dependent diabetes mellitus (IDDM) is insulin replacement via parenteral 
routes which is far from satisfactory, because injection is generally a painful procedure, especially when 
patients need to get the injections throughout their life by 2-3 injections/day. Secondly, many patients 
have phobia against injections especially children. Thirdly, insulin is expensive to purchase. Fourthly, 
parenteral insulin is not safe in the long-term of uses as development of anti-insulin antibodies is 
possible, and fifthly, parenteral insulin is associated with the risk of hypoglycemic events. For those 
reasons, raw dromedary’s camel milk is an alternative and or complementary to pareneral insulin 
treatment of IDDM. This paper discusses the chemical constituents and properties of dromedary’s camel 
milk, recent research about its efficacy in the treatment of IDDM, its role in the restoration of 
experimentally damaged beta-cells of the pancreas, its role in the improvement of lipid metabolism, 
body mass index and functions of the kidneys and liver of subjects with IDDM received camel milk. 
This paper demonstrates that, raw dromedary’s camel milk causes significant reduction in insulin doses 
in insulin dependent diabetic subjects to obtain glycemic control along with significant hypoglycemic 
effects. Significant improvement were also observed in HbA1c levels, micro albuminuria, lipid 
metabolism, BMI, biochemical parameters of the liver and kidney functions of camel milk fed 
experimental subjects with IDDM. Camel milk works as a regulator of blood sugar in the absence of 
original insulin, and it seems to work together with the body’s own restorative and regenerative abilities 
to maintain normal health. Camel milk is well tolerated and its uses are not associated with the risk of 
hypoglycemic events, and it may be able to eliminate the alloxan and other chemicals’ induced-
toxicity on pancreas and on other body’s organs via regenerative effects on damaged cells w i t h  
u n k n o w n  m e c h a n i s m  and could be used as an alternative and or a complementary treatment 
to current IDDM therapy.  
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 جلاعلل لمكم و ليدب جلاع لبلإا بيلحنيلوسنلأاب نقحلاب نيلوسنلأا ىلع دمتعملا يركسلا ضرمل يلاحلا  
يبرع صلختسملا 
 حيرم ريغ جلاعلا اذه و ،نقحلا قيرط نع نيلوسنلأا وه نهارلا تقولا يف نيلوسنلأا ىلع دمتعملا يركسلا ءادل سيئرلا جلاعلا نإ
 نم ديدعلاب بوحصمو نيلوسنلأا ىلع دمتعملا يركسلا يضرم نم ريبك عاطقل ًامومع ةملؤم ةيلمع نقحلا  نلأ ،رطاخملاو بويعلا
 نوناعي صاخشأ كلانه :ًايناث ،مويلا يف تارم ثلاثل نيتنقح لدعمب ةايحلا ىدم نيلوسنلأاب نقحلا رمتسي ثيح يركسلا ىضرمل ةصاخو
وسنلإا :ًاثلاث ،لامهإب اهنولمعتسي وا مهضرم ةعيبط تناك امهم اهنولمعتسي لاو نقحلا نم عذجو فوخ نادلبلا يف ةصاخ فلكم نيل
 نقح اذإ مدلا ركس يف يئاجف داح صقن ثودح ةيناكما :ًاسماخو ،نيلوسنلإا دض ةداضملا ماسجلأا روطت ةيناكمإ كلانه :ًاعبار ،ريقفلا
مانسلا تاذ لبلإا بيلح دعي بابسلأا هذهلو .رطخلل هتايح ضرعي امم نايسنلا وأ لهجلا ببسب عوجلا ىلع نيلوسنلإا ضيرملا ا دحاول
 و لبلإا بيلحل ةيئايميكلا تانوكملا ةساردلا هذه ثحبت .يلاحلا نيلوسنلأا ىلع دمتعملا يركسلا جلاعل لمكم وأ ليدب جلاع جزاطلا
 بيلح رودو ،نيلوسنلأا لع دمتعملا يركسلا ءاد جلاع يف لبلإا بيلح ةيلاعف تلوانت يتلا ثاحبلأا رخآو ،اهب زاتمي يتلا صئاصخلا
عإ يف لبلإا و ىلُكلا فئاظو و نيسحت و ،نوهدلا بلاقتسا نيسحت و ،ىرخلأا مسجلا ءاضعاو ةلطعملا ةيسايركنبلا اتيب ايلاخ ءايحإ ةدا
.دبكلا 
 ًادج لاعف ريثأت هلو ،مدلا ركس ىوتسم طبضل ةيرورضلا نيلوسنلأا ةعرج ةريبك ةجردب ضفخي لبلإا بيلح نأ ةساردلا هذه ترهظأ دقل
دلا ركس زيكرت ضفخ يف تارشؤملا و ،مسجلا ةلتك رشؤمو ،نوهدلا بلاقتساو ،لوبلا نيمويبلآ و ،يمكارتلا ركسلا ىوتسم نسحي و ،م
 ودبي نأشلا اذه يفو ،لصلأا نيلوسنلأا بايغ يف مدلا ركس ىوتسمل مظنمك لبلإا بيلح لمعي امك ،ىلُكلاو دبكلا فئاظول ةيئايميكويبلا
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خلأا مسجلا تايلآ عم لمعي لبلإا بيلح نأ كلتمي امك .ةديج ةحص ىلع ظافحلا يف مسجلا تاردقم ءايحإ و ديدجت ةداعإ يف ةفلتخملا ىر
 داوملا ضعبو ةدسكؤملا داوملا ببسب ىرخلأا مسجلا ءاضعأو سايركنبلا بيصي يذلا فلتلا و ةيمسلا ةلازإ ىلع ةردقملا لبلإا بيلح
لإاو يديدجتلا هريثأت للاخ نم كلذو ىرخلأا ةماسلا ةيئايميكلا رطاخملاو بويعلا لك نإ .ةفورعم ريغ تايللب ةفلاتلا ايلاخلا ىلع يئايح
 اهببسي يتلا
 جلاع
 ىلع دمتعملا يركسلا ءادب نيباصملا ىضرملا ةطساوب هلوانت نإو لبلإا بيلح اهببسي لا ًاقباس تركذ يتلاو نيلوسنلإا نقحب يركسلا
 لبلإا بيلح لامعتسا نكمي كلذلو .ًامامت نمآ نيلوسنلأا.نيلوسنلأا ىلع دمتعملا يركسلا ءادل لمكم وأ ليدب جلاعك     
 
1. General Introduction 
Diabetes mellitus (DM) is one of the most prevalent and serious chronic diseases to humans in 
nearly all countries. In 2011, the disease affected 366 million people worldwide, of which 4.6 
million lost their lives (1). The number is expected to have risen to 552 million by 2030 (1).  The 
prevalence of DM is particularly higher in low- and middle-income countries, which constitutes 
80% of the people living with diabetes (1). For instance in Sudan, a developing country in 
Africa, DM affects 2 million people; which is about 6% of its population, and the prevalence 
is about 20% in the capital Khartoum (2). On the other hand, in 1999-2002, more than 9% of 
people 20 years of age and over and 25% of adults 60 years and over had diabetes in the USA, 
an indicator about the prevalence of DM in the developed world. In the USA the prevalence 
rates of DM was doubled between 1990 and 2005 (3, 4). Prevalence and mortality from DM in 
China and other Asian nations is high and is on the increase (5, 3). Study of the diabetes is 
important in order to allocate community and health resources and encourage measures to 
counteract trends for increasing prevalence.   
2. Diabetes Mellitus 
 DM is a group of metabolic disorders characterized by chronic hyperglycemia resulting from 
defects in insulin secretion, insulin action, or both. There are two major types of DM: insulin 
dependent DM (IDDM) and non-insulin dependent DM (NIDDM).   
IDDM is an organ specific autoimmune disease, characterized by loss of the insulin-producing 
beta cells of the islets of Langerhans in the pancreas. This loss of beta cells leads to insulin 
deficiency. IDDM can be further classified as immune-mediated or idiopathic. The majority of 
IDDM is of the immune-mediated nature, in which beta cell loss is a T-cell-mediated 
autoimmune attack.  
Before the advent of insulin, diabetes was treated with medicines derived from natural sources 
(5, 6, 7, 8,9and10). Recently, the search for appropriate anti-hyperglycemic agents has been focused 
on the types of food used in traditional medicine, because these medicines are natural products, 
not drugs (11).  
 
The main treatment of insulin-dependent diabetes mellitus (IDDM) is insulin replacement via 
parenteral routes which is far from satisfactory, because injection is generally a painful 
procedure, especially when patients need to get the injections throughout their life by 2-3 
injections/day. Secondly, many patients have phobia against injections especially children. 
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Thirdly, insulin is expensive to purchase. Fourthly, parenteral insulin is not safe in the long-
term of uses as development of anti-insulin antibodies is possible, and fifthly, parenteral insulin 
is associated with the risk of hypoglycemic events. For those reasons, raw dromedary’s camel 
milk is an alternative and or complementary to pareneral insulin treatment of IDDM. 
To overcome the drawbacks of parenteral insulin therapy, scientists have developed oral 
insulin, hexyl-insulin monoconjugate-2 (HIM2), in which a single amphiphilic olignmer is 
covalently linked to the free amino group on the lys29 residue of recombinant human insulin 
via an amide bond (12,13). HIM2 alterations in physico-chemical properties are a characteristic 
which resists the enzymatic degradation and facilitates absorption of the modified insulin. Oral 
insulin therapy presumably rated the best treatment, but it also has several drawbacks, some of 
them are: it takes more time and efforts, it is expensive, and its coagulum formation nature in 
the stomach due to acidic environment reduces its effectiveness and it is accompanied with 
constant episodes of abnormally hypoglycemia and gain in weight (14). These drawbacks have 
forced people to adopt alternative therapies (14). 
2.1. Consequences of uncontrolled DM 
DM is defined as a state of chronic hyperglycemia associated with dysfunction of carbohydrate 
metabolism. Eventually, dysfunction of carbohydrate metabolism leads to lipid, proteins and 
nucleic acid metabolism (24). Moreover, chronic hyperglycemia causes long-term damage, 
dysfunction, and failure of various organs of the body. The most suffered organs are the eyes, 
kidneys, nerves, heart and blood vessels (15).  Furthermore, untreated diabetes causes a number 
of serious acute and long-term complications. Acute complications include hyperglycemia, 
diabetic ketoacidosis, or non-ketotic hyperosmolar coma. Serious long-term complications 
include cardiovascular disease, chronic renal failure, and diabetic retinopathy, the later is 
notably responsible for 8% of blindness in the US (16).  
 
DM is the leading cause of new cases of blindness in the world. Each year 12.000 to 24.000 
people lose their sight because of DM and are the leading cause of new cases of blindness in 
adults at the age of 20-74 years old (16). In addition, 78.000 children develop IDDM every year 
and it interrupts normal child development and carries the threat of severe complications in the 
active period of their lives (17). There is no known preventive measure against type 1 diabetes, 
which causes approximately 10% of DM cases in North America and Europe. Most affected 
people are otherwise healthy and of a healthy weight when onset occurs. IDDM can affect 
children or adults, but was traditionally termed "juvenile diabetes" because majorities of these 
diabetes cases were in children. DM interrupts normal child development and carries the threat 
of severe complications in the active period of their lives. It is therefore, urgently needed to 
search for safe and more effective therapies for DM, either as complementary and or an 
alternative to existing treatment programs as no drug has been shown to modify the course of 
diabetic complications (13,18).  
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An alternative to current insulin treatment of DM is Camelus dromedaries milk 
(18,19,20,21,22,23,24,25,26,27and28). Also, Camelus dromedary’s milk has shown to have exceptional 
broad and very useful therapeutic qualities on other serious human diseases (24, 29, 30,31and32). 
In the next pages, I discus the chemical constituents and properties of dromedary’s camel milk, 
recent research about its efficacy in the treatment of IDDM, its role in the restoration of 
experimentally damaged beta-cells of the pancreas, its role in the improvement of lipid 
metabolism, body mass index and functions of the kidneys and liver of subjects with IDDM 
received camel milk.  
 
3. Chemical constituents and properties of dromedary’s camel milk 
Dromedary’s camel milk chemical composition is different from that of other mammals. 
3.1. Water content in dromedary’s camel milk 
Camel milk has high percentage of water content, which ranges from 86-91% (19), and it is 
inversely proportioned to the availability of drinking water to camels. This makes camel milk 
a valuable source of water for suckling young camels and the camel herdsmen who normally 
live in scarce water areas. The first camel milk after delivery, the colostrums, is white and 
slightly diluted as compared with the colostrums of cow. Its 3 hours post-partum total solids 
(T.S) averaged 30.4% (33), and it declines to 18.4% during the first 2 days of lactation. This 
decline in T.S. is then greatly decreased to 5.8% and is rather caused by a decline in total 
proteins and minerals (33).  
3.2. Puissance hydrogen of dromedary’s camel milk 
Fresh dromedary’s camel milk has a pH of 6.4± 0.18 (18). This pH of the milk allows enhanced 
absorption of milk constituents from the duodenum, especially the iron. When camel milk is 
left to stand, the acidity rapidly increases (24). The lactic acid content increases from 0.03 
percent after standing 2 hours to 0.14 percent after 6 hours (24). 
3.3. Insulin in dromedary’s camel milk 
Camel milk contains high concentration of insulin i.e. 52 U/L (20) to 59 U/L (34). The milk also 
contains one protein that possesses many characteristics similar to human insulin (21). Camel 
milk is not affected by acidic environment and does not form coagulum in acidic environment 
such of the stomach (22).  This lack of coagulum formation allows the camel milk to pass rapidly 
through stomach together with the specific like protein/insulin and remains available for 
absorption in intestine. It was proposed that, this unique property of camel milk gives it the 
advantage to serve as a vehicle and a protector that facilitates the absorption of intact molecules 
of insulin by the small intestine (14).  
3.4. Fats in dromedary’s camel milk 
Dromedary milk is pure white as the fats are finely homogenized throughout the milk. Camel 
milk contains little fat, in average about 2%; and this fat consists mainly of polyunsaturated 
fatty acids that are completely homogenized and gives the milk its smooth white appearance 
  
EDITORIAL  
 
Gezira Journal Of Health Sciences 2016 vol.12(2) 
Gezira Journal Of Health Sciences 2016 vol.12(2) 
(24). Camel milk has high concentrations of volatile acids especially the essential fatty acid, 
linoleic acid and other polyunsaturated fatty acids, which are essential for human nutrition (30). 
Fats in camel milk dispersed as small micelles instead of a layer that are non-reactive to acid 
(35). Camel milk is low in cholesterol about 40-folds lesser than cholesterol concentration in 
caw milk (24).  
3.5. Vitamins and minerals in dromedary’s camel milk 
Camel milk has high concentration of ascorbic acid (vitamin C) of 5.7-9.8%, which is 3 times 
greater than of other mammalian milks (36). Camel milk is also rich in other vitamins such as 
B12, E, B1, B2 and A. Camel milk has high concentrations of minerals such as calcium, iron, 
magnesium, cupper, manganese, sodium, phosphorus, zinc and potassium (24).  
3.6. Sugars in dromedary camel milk 
Dromedary’s camel milk contains lactose in average concentrations of 4.8%, but this milk 
sugar is easily metabolized by persons suffering from lactose intolerance (24). 
3.7. Proteins, enzymes and immunoglobulins in dromedary’s camel milk 
The proteins of camel milk do not cause food allergies, because camel milk contains no beta-
lactoglobulin (37) and a different beta-casein (38), the two proteins in cow milk that are 
responsible for allergies.  
Immunoglobulins IgM, IgG, IgA and IgD have been detected in camel sera on the basis of 
cross-reactivity with human immunoglobulins (39). Camel immune system is different from all 
other mammalians (40). Camel milk immunoglobulin subclasses IgG2 and IgG3, which are 
natural for camels, consist of only two heavy chains. Light chains (VL) are not present. These 
are naturally occurring antibodies devoid of light chains. There is a single V domain (VHH) 
(41).  Camel milk IgG2 and IgG3 VHH have a long complementary determining region (CDR3) 
loop, compensating for absence of the VL (42). The  conventional immunoglobulins  are  large  
long  and  short-chained  domains,  having  difficulties  reaching  and  penetrating  antigens.  
As camel immunoglobulins have no short chains and small so are active against antigens. The 
camel’s immunoglobulins pass into the milk and so are available for combating autoimmune 
diseases. The most  pertinent  factor is that  conventional treatments of  autoimmune diseases  
are  based  on  immune-suppression,  while  camel  milk  immunoglobulins enhance  the  
immune  system, thus revitalizing immune integrity (31,33). 
Viral  enzymes play  a  key  role  in  triggering  diseases,  and  by  neutralizing them a replication 
of  viruses would stop. A camel variable domain antibody fraction is a potent and selective 
inhibitor of the Hepatitis-C enzyme system (4). This explains the extreme resistance to many 
deadly animal viral diseases like Foot & Mouth, Rift Valley fever and Rinderpest (39). 
Conventional antibodies rarely show a complete neutralizing activity against enzyme antigens. 
Camel milk IgG has a full neutralizing activity against tetanus toxin as it enters the enzymes 
structure.  Camel hypervariable regions have increased repertoire of antigen binding sites (42). 
Camel milk IgG2 and IgG3 VHH domains are better suited to enzyme inhibitors than human 
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antibody fragments (41), thus offering a potential for viral enzymatic neutralization (44). 
Camel  milk  contains  various  other protective  proteins,  mainly  enzymes  which  exert 
antibacterial and immunological properties (45).  The protective proteins in camel milk, include, 
N-acetyl-glucosaminidase (NAGase), the  milk  enzyme,  NAGase  is an  accepted test for 
mastitis in cows. When it was first documented that camel milk was rich in NAGase  it  was  
assumed  that  those  camels  suffered  from  subclinical  mastitis.  However after checking 
camel and llama’s milk (46) all with high NAGase levels, it was concluded that NAGase has an 
antibacterial activity and so strengthens the antibacterial-antiviral activity of the milk. It is 
noteworthy that the  NAGase  activity  is  similar  to  that  in  women's milk,  confirming  the  
nutritional advantages of camel milk over cow milk.  
Camel milk contains lysozymes, which participate in primary immune system. Lactoferrin, 
which are iron-saturated lactoferrin and prevents microbial growth in gut, participates in 
primary immune system. Camel milk apparently contains much more lactoferrin than in 
ruminant milk (46). Lactoperoxidase in camel milk contributes to the non-immune host defense 
system and exerting bactericidal activity, mainly on gram-negative bacteria it has growth 
promotion activity and anti-tumor activity (47), and is analogue of 71% to human thyroid 
peroxidase, which is involved in iodination and coupling in the formation of the thyroid 
hormones. Camel milk has the highest concentrations of peptidoglycan recognition protein 
(PGRP) among milks of other mammals. This protein was discovered in camel milk and it has 
apparent effect on breast cancer (48) by controlling metastasis (49). It stimulates the host’s 
immune response. It has a broad antimicrobial activity. 
4. Recent research on the efficacy of the dromedary camel milk in the treatment of IDDM 
Patients with type 1 diabetes suffer chronic hyperglycemia and dysfunction of carbohydrates, 
fat and protein metabolism (51).  
4.1. The efficacy of dromedary’s camel milk in the treatment of IDDM in lab animals 
Effect of camel milk in comparison to cow’s milk on blood glucose, triglycerides, alanine-
amino transferase (ALT) and asparate-amino transferase (AST) levels in healthy female albino 
rats was studied (52). At the end of the study period, rat blood samples were analyzed. No 
significant difference in glucose, triglyceride, AST and ALT activity was detected between the 
control and treated groups. But cholesterol levels of both 100% cow and 100% camel milk 
treated rats were shown to be significantly lesser than control group. It can be concluded from 
this study that camel milk can be safely consumed by non-diabetics or healthy individuals. 
Study to analyze the anti-diabetic effects of camel milk in streptozotocin-induced diabetic rats 
by assaying liver and kidney clinical function parameters was conducted (53). Administration 
of streptozotocin to the experimental groups of rats resulted in marked detectable changes. The 
rats were fed daily with fresh camel milk for 30 days. The effects of camel milk on blood 
glucose, serum proteins, blood urea, uric acid, creatinine, lipid profile and the activities of 
diagnostic marker enzymes of liver and alkaline phosphatase (ALP) in the plasma/serum of 
  
EDITORIAL  
 
Gezira Journal Of Health Sciences 2016 vol.12(2) 
Gezira Journal Of Health Sciences 2016 vol.12(2) 
control and experimental groups of rats were evaluated. The results of this study showed that, 
camel milk feeding to diabetic rats significantly reduces the levels of blood glucose, urea, uric 
acid and creatinine and increases the activities of albumin, albumin/globulin ratio and restores 
all liver function marker enzymes and lipid profile to near control levels. The data of this study 
demonstrated that camel milk has anti-hyperglycemic effects and alleviate liver and renal 
damage associated with streptozotocin-induced diabetic mellitus. 
The hypoglycemic effect of camel milk in comparison to cow and buffalo milks in 
stretozotocin-induced diabetic rats was carried out (34). The effects of camel, cow and buffalo 
milks on liver and kidney functions of the diabetic rats in comparison to a control group and 
groups fed with cow and buffalo milks were also investigated. The study revealed that, camel 
milk was most effective in hypoglycemic control of the diabetic rats; it reduced hyperglycemia 
by 49.2%, while cow and buffalo milks reduced hyperglycemia by 11.6% and 11.1% 
respectively. Also, camel milk improved liver enzyme functions of alanine-amino transferase 
and aspartate amino transferase by 41 and 38% respectively compared to cow and buffalo milk 
fed diabetic group. Also, camel milk showed significant normalization effects in blood uric 
acid, urea, and creatinine of the diabetic study group. The findings of this study demonstrated 
that, camel milk has marked glycemic control and positive effects on liver and renal functions 
of diabetic subjects. 
Efficacy of camel milk on alloxan-induced diabetic dogs was investigated (18).  Alloxan 
injection caused a toxic effect on kidney and liver in addition to the pancreas. Two diabetic 
dog groups: group 1, received 0.5 L raw camel milk. Group 2 received 0.5 L raw cow milk, 
an additional third healthy group of dogs was used as control; these dogs received 0.5 L raw 
camel milk. By the end of the study, group1 showed a significant decline in blood glucose, 
cholesterol and total proteins. In the contrary, group 2 showed hyperglycemia, increase in 
cholesterol, and increase in total proteins. The diabetic state of group 2 was confirmed by 
glucose tolerance test. After then, the dogs of group 2 were treated, in test 2, with 0.5 L camel 
milk for 5 weeks instead of cow milk. At week 4, blood glucose level for these dogs showed 
a significant decrease, a similar improvement was occurred in total proteins and in cholesterol. 
Dogs from group1, which were used to follow the effect of camel milk by the end of 
experiment, showed healthy state: normal blood glucose levels, normal cholesterol, normal 
triglycerides and normal total proteins. The stability of the glycemic state of dogs received 
camel milk was c o n f i r m e d  by glucose tolerance test (GTT). The steadiness of this 
glycemic state w as  obs e r v ed  since week 3 and after stopping of camel milk. The results 
of this study clearly demonstrated that, camel milk has a therapeutic effect on alloxan-induced 
diabetic dogs and restoration of the pancreatic function. 
Therapeutic effects of camel milk on streptozotocin-induced diabetic male albino rats were 
studied (54). The levels of total cholesterol (TC), triglycerides (TGs) free fatty acids (FFAs), 
phospholipids (PLs), high density lipoprotein-cholesterol (HDL-C), low density lipoprotein-
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cholesterol (LDL-C)  and very low density lipoprotein-cholesterol (VLDL-C) were assayed in 
the plasma and tissues of the liver, kidneys and heart of a control (received no camel milk) and 
a studied group (received camel milk). By the end of the study they observed significant 
increase in total cholesterol, triglyceride, free fatty acids, LDL-C and VLDL-C in plasma and 
tissues of the streptozotocin-induced diabetic male albino rats, while plasma HDL- cholesterol 
was significantly decreased in the group. Treatment of these rats with camel milk helped to 
cure the above changes till normal. Thus, this study demonstrated that, camel milk was good 
in reducing hyperglycemia and hyperlipidemia associated with diabetes mellitus. 
A study to investigate the effects of camel milk in comparison with insulin in the treatment of 
experimentally-induced diabetes was carried out by (55) on New Zealand rabbits. The rabbits 
were divided into 4 groups by 10 rabbits each. Group1 was control, non-diabetic and received 
normal saline only. The other 30 rabbits were injected intravenously with alloxan for induction 
of diabetes mellitus and then divided into 3 groups, ten rabbits in each as following: group 2 
considered as control diabetic and left untreated, group 3 was considered as diabetic and treated 
with insulin, and group 4 was considered as diabetic and received camel milk. At the end of 
the study, blood and tissue samples (liver, kidney and pancreas) were collected from all the 
rabbits for analysis of enzymatic superoxide dismutase (SOD) activity and catalase, non-
enzymatic glutathione (GSH) antioxidant enzyme activities. Serum malondialdeyde, glucose, 
insulin and lipid profile were also analyzed. The results of the study showed that, camel milk 
was effective in the treatment of the induced diabetes in comparison to insulin treatment alone. 
In addition to that, camel milk helped to improve the diabetes-induced oxidative stress. The 
histopathological examination of tissues of these animals revealed that, there was regeneration 
of β cells and the islets of Langerhans among the pancreatic acini in rabbits receiving camel 
milk. These findings suggested that the camel milk administration in case of insulin dependent 
diabetes mellitus might be recommended as an oral anti-diabetic remedy for this chronic 
disease. 
The effects of raw camel milk on male albino rats that were rendered diabetic by a single intra 
peritoneal injection of streptozotocin were studied (28).  Streptozotocin induced diabetic 
rats were randomized to receive raw camel milk, pasteurized camel milk, raw camel milk + 
lactoferrin, or cattle milk and control [non diabetic rats (n=8)] which were followed for 4 weeks. 
There was significant difference with raw camel milk, this difference is decreased after 
pasteurization and there was no added advantage after adding lactoferrin. The present study 
indicates that there was significant decrease in mean blood sugar level in diabetic rats 
getting raw camel milk. There were no added advantages of adding lactoferrin in raw camel 
milk. Hypoglycemic activity of camel milk decreases after pasteurization. This study showed 
that, raw camel milk may be a therapeutic adjunctive option for diabetes mellitus in humans. 
 
4.2. The efficacy of dromedary’s camel milk in the treatment of IDDM in humans 
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Effect of oral insulin carried by camel milk on type 1 diabetes patients in comparison with 
both insulin injection requirements and camel milk alone was studied (14).  Fifty randomly 
selected type 1 diabetic patients were divided into three groups; A, B and C. Group B in 
addition to usual care received 0.5 L of camel milk daily, while group C in addition to usual 
care received insulin mixed with 0.5 L ml of camel milk daily. Results of  th i s  s tudy 
showed  significant improvements in fasting blood sugar,  post parandial blood sugar, HbA1c 
and significant reduction in insulin requirement in group C receiving insulin mixed with camel’s 
milk in comparison with groups A and B. This study proved that camel milk mixed with insulin 
was effective supplementation, as adjunctive therapy in management of type 1 diabetes. 
A randomized study to evaluate the efficacy of camel milk as an adjuvant therapy in young 
type 1 diabetic patients was achieved by (56). They enrolled 54 type 1 diabetic patients with an 
average age of 20 years. Subjects were randomly divided into two groups of 27 patients. Group 
1 received usual management, whereas group 2 received 500 ml of camel milk daily in addition 
to standard management as for group 1. A third group, annotated as a control group of 10 
healthy subjects was also assessed. After the study period, significant differences were 
observed between the usual-management groups versus the camel milk received group: fasting 
blood sugar, HbA1c, Serum anti-insulin antibodies, Urinary albumin excretion, daily insulin 
dose and body mass index. C-peptide levels were markedly higher in the camel milk received 
group. The results of this study has shown that, 500 ml daily consumption of camel milk by 
type 1 diabetic patients as an adjunct to standard management of DM; can better manage DM 
and improve metabolic control. 
The efficacy of camel milk as an adjunct to routine diabetic management in maintaining long-
term glycaemia control in type I was assessed by (57).  Throughout the study, 12 randomly 
assigned patients underwent routine diabetic management and 12 randomly assigned patients 
additionally undertook daily consumption of raw camel milk (500ml/day).  Glycosylated 
haemoglobin (HbA1c) and BMI were measured at the initiation of the study and monitored at 
3 monthly intervals. Additionally, plasma insulin, C-peptide and anti-insulin antibodies were 
measured at the beginning and end of the study. In the group receiving camel milk, there was 
a significant increase in MBI and a significant reduction in HbA1c, mean blood glucose and 
necessary insulin dose compared to the values at the initiation of the study. In addition to 
that, one patient of the group is completely cured from DM after 8 months of 
consumption of camel milk, and gets rid of using insulin totally. In the contrary, there  
was no significant change in c-peptide or anti- insulin antibodies. This study demonstrated 
that, camel milk, as an adjuvant to insulin therapy, was safe and efficacious in improving long-
term glycaemic control, and helps in the reduction of insulin requirement in type 1 diabetic 
patients.  Camel milk was well tolerated and its use was not associated with an increase in 
hypoglycemic events. 
Efficacy of camel milk on glycemic control, risk factors and diabetes quality of life in patients 
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of type 1 diabetes was studied by (58). Twenty four randomly selected patients with type 1 
diabetes were enrolled in this study. They divided the patients into two groups. Group 1 (12 
patients) received usual care and group 2 (also 12 patients) received 500 ml camel milk in 
addition to usual care. Baseline data of both groups were similar in demographic and variables. 
After 3 months of treatment there were significant improvements in fasting blood sugar and 
HbA1c levels and significant reduction in insulin requirement in patients receiving camel milk. 
Diabetes quality of life score improved significantly in the form of change in satisfaction. There 
was 30% reduction in doses of insulin in 92% of patients of group 2. However, there was no 
statistically significant changes in lipid profile, plasma insulin and c- peptide. This study 
showed that, camel milk proved effective supplementation in the management of type 1 
diabetes.  
5. Discussion and Conclusions: 
Besides drugs (insulin, sulphonylureas and biguanides), classically used for the treatment of 
diabetes, consumption of camel milk is a common practice in Africa, Asia and the Middle 
East for  the treatment of diabetes mellitus. Camel milk is well known, in arid and semi-arid 
regions, for its medicinal properties (24).  
Camel milk contains high concentration of insulin; this may be the reason for lesser 
requirement of insulin in camel milk feeding groups with diabetic mellitus. Oral insulin has 
been known since many years but its drawbacks such as its coagulum formation in acidic 
environment in stomach thereby neutralizing its potency (24). The lack of coagulum formation 
in acidic media of camel milk may act as an effective vehicle to take the insulin present in 
it unchanged to the intestine and from there it can be absorbed. Moreover, amino acid 
sequence of some of the camel milk proteins is rich in half cystine has superficial similarity 
with insulin family of peptides were reported (21). 
Electrophoresis of camel’s milk and shubat’s proteins and their microelement compositions 
were determined (59). Electrophoresis revealed two bands in camel's milk and several in 
shubat. Camel milk was shown to be low in fat and contains no cholesterol. It contains lower 
lactose, higher levels of potassium, iron and vitamin C, and large concentrations of insulin (20, 
59).  
Diabetes mellitus is defined as a state of chronic hyperglycemia associate with dysfunction 
of carbohydrate metabolism. Dysfunction of carbohydrate metabolism, eventually leads to 
dysfunction of lipid, carbohydrate and nucleic acid metabolism (24). The metabolic disorders 
of diabetes mellitus can be induced experimentally by injection of alloxan or streptozotocin to 
experimental animals. Alloxan induced-diabetes is caused by the selective pancreatic beta cell 
toxicity (60, 61).  In order to destroy insulin- producing cells and to induce a state of insulin-
dependent diabetes mellitus, alloxan is structurally analogue to glucose, and is taken up into 
the cell via the low affinity GLUT 2 glucose transporters in the plasma membrane (62). Several 
species such as rats, rabbit and dogs are sensitive to alloxan toxicity (63). Alloxan-induced 
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diabetes causes minimal beta cell activity, hyperglycemia, hypercholesterolemia and 
hyperproteinaemia (18).  Alloxan injection causes damage to kidneys, liver and the pancreas 
(64).  
The toxicity of alloxan to kidneys may be attributed to its toxic effects on the proximal 
convoluted renal tube (65). Camel milk causes significant decrease in blood glucose on alloxan-
induced diabetic dogs (18).  The hypoglycemic effect of camel milk appeared since week 3 of 
giving the milk to experimental animals and continuous up to normal levels of blood 
glucose (18).  The stability of the glycemic state was c o n f i r m e d  by GTT. This stability was 
associated with decline in cholesterol concentrations and this steadiness last  after ceasing 
camel milk (18). 
Since blood glucose, proteins and lipids profiles were controlled by endocrine, paracrine and 
autocrine interactions; there might be more active principles in camel milk (66) that warrant 
further study. High mineral contents of camel milk s u c h  a s  i r o n ,  sodium, potassium, 
copper and magnesium and high level of vitamin C may act as antioxidants that scavenge free 
radicals from the cells; this might provide additional benefit to camel milk (67, 68). Camel milk 
could eliminate the alloxan and other chemical toxicities on pancreas, liver and kidney via 
regenerative effects on damaged cells and could be used as a restorative treatment of diabetes 
(24). Removal of free radicals by camel milk prevents tissues damage including t h e  β-cells 
of t h e  pancreas (75). Free radicals play a role in the enhancement of oxidation of LDLs and 
the exhaustion of HDLs. The two opposing processes are atherogenic. T h e  high 
concentrations of antioxidants i n  c a m e l  m i l k  and the effects of camel’s milk in lowering 
body fats in healthy individuals and in patients with IDDM might hone the  insulin receptors 
to become more responsive to available insulin in camel milk. The regenerative abilities of 
dromedary’s camel milk on damage pancreas and other organs might be due to stem cells like 
principles or a novel mechanism that warrant further investigations and elucidation. 
Hypoglycemic effect of camel milk is slower when the diabetic animals were previously 
treated with cow milk. This might be due to the fact that, cow milk proteins might serve as a 
trigger for the development of diabetes in susceptible subjects. In this context, elevated levels 
of anti-bovine serum albumin antibodies were detected in diabetic animals and patients (69, 68).  
The efficacy of camel milk in the treatment of allaxan-induced diabetes mellitus may have an 
important implication for the management of diabetes mellitus in humans. But further studies 
are warranted to elucidate the exact mechanisms of action of camel milk. 
There are strong evidences that oral insulin products would provide insulin in a more effective 
physiological manner, resulting in a decrease in peripheral insulin concentrations thus 
“insulinsing” the live (70, 71). Consumption of milk for the treatment of DM is itself a point of 
contention as insulin, being a protein, is normally destroyed   in   the   stomach   (72). Intestinal 
absorption of large proteins and, therefore, insulin is only possible in the first few days of life 
(73).  
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Camel milk contains high amounts of ascorbic acid (36); it does not react to the acid and does 
not form coagulum in acidic environment (22). These properties might allow camel milk to pass 
readily to the intestines for absorption with its intact insulin molecules. Lack of coagulum 
formation of camel milk in acidic media and its antibacterial and antiviral activities might lie 
behind the efficacy of camel milk in the treatment of IDDM (74).  The decline in blood glucose 
following camel milk consumption validates the fact that camel milk acts on regulating cellular 
sugar in the absence of endogenous insulin and in the presence of exogenous oral insulin. 
Healthy individuals with low BMI and diabetic patients who consumed camel milk, showed 
significant improvement in mean BMI (24). The positive effect in weight gain and corrections 
of lipid profile in individuals consuming camel milk might be attributed to camel milk high 
nutritional value, relative lower fat percent and extremely low cholesterol. Camel milk is 
very nutritious, tonic and has a high satiety value. It possesses hypoallergenic, antibacterial, 
antiviral, hypoglycemic and other medicinal properties and fully compatible with human milk 
(24). Camel milk is the most beneficial for human nutrition (76). Nutrition plays a vital role in 
health maintenance and in the prevention of diseases. There was marked improvement in 
diabetes quality of life score of camel milk treatment; this could be a result of an improved 
glycemic control or anabolic effect of camel milk with good amount of lysozyme, lactoferrin, 
lactoperoxidase, immunoglobulin Gs and secretory immunoglobulin in camel milk. 
Interestingly, fats of camel’s milk disperse in small micelles in instead of a large layer, this in 
contrast of milk of other mammals. Moreover, camel milk is non-reactive to acid and the 
churning effect of the stomach and the quality and quantity of these fats are largely different 
from those of other mammals. The existence of fats in the form of small micelles might allow 
one to postulate that, these fat micelles might form particles, capsules or a kind of 
conjugates with insulin and insulin-like molecules of camel milk with persistent qualities 
to pepsin digestion and facilitate insulin’s absorption as intact molecules through the small 
intestine. Strong buffering capacity of camel milk and insulin-analogue peptides of camel milk 
with rich cystine repeats are also interesting and warrant further studies. 
In conclusion, raw dromedary’s camel milk causes significant reduction in insulin doses in 
insulin dependent diabetic subjects to obtain glycemic control along with significant 
hypoglycemic effects. Significant improvement were also observed in HbA1c levels, micro 
albuminuria, lipid metabolism, BMI, biochemical parameters of the liver and kidney functions 
of camel milk fed experimental subjects with IDDM. Camel milk works as a regulator of blood 
sugar in the absence of original insulin, and it seems to work together with the body’s own 
restorative and regenerative abilities to maintain normal health. Camel milk is well tolerated 
and its uses are not associated with the risk of hypoglycemic events, and it may be able to 
eliminate the alloxan and other chemicals’ induced-toxicity on pancreas and on other body’s 
organs via regenerative effects on damaged cells with unknown mechanism and could be used 
as an alternative and or a complementary treatment to current IDDM therapy.   
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